Healthcare leaders reacted to President Biden’s withdrawal from the 2024 presidential race. Biden made the announcement on Sunday afternoon following debates surrounding his physical and mental abilities to serve another term. He followed the announcement with an endorsement of Vice President Kamala Harris as the democratic presidential nominee. (MM+M)
Agilent Technologies said it will acquire contract drug manufacturer Biovectra for $925 million to expand its portfolio of services offered to biotech companies and medical researchers. Canada-based Biovectra offers fill-and-finish services for drug manufacturers and also operates a business that makes active ingredients for complex drugs and has expertise in fast-growing segments such as the GLP-1 weight loss drugs. (Reuters)
China’s WuXi AppTec spent at least $360,000 lobbying on the Biosecure Act and other bills before Congress in the second quarter. This represents a significant upping of its lobbying efforts on Capitol Hill. The Unfold AI technology showed 84% accuracy while physicians showed 67% accuracy. (Endpoints News)
Doctors, scientists and activists have convened in Munich at the 25th International AIDS Conference. The conference serves as a forum to discuss advancements and plan for a possible cure for AIDS, which still, decades into the epidemic, remains a massive threat. (The Economist)
Take an inside look at how a single daily pill could soon be the future of losing weight.
Fear of jabs has pharma companies scrambling to be the first to launch the ‘holy grail’ of obesity drugs. (The Telegraph)
Click here to view yesterday’s Five things for pharma marketers to know.
